Cargando…
Fixed-drug Eruptions: What can we Learn from a Case Series?
BACKGROUND: A fixed-drug eruption (FDE) is a unique cutaneous adverse drug effect in the form of recurrent lesions at the same site after re-exposure to the offending agent. AIM: The aim of the study was to identify changes in trends in fixed drug eruptions with regard to causative drug or patient r...
Autores principales: | Jhaj, Ratinder, Chaudhary, Deepa, Asati, Dinesh, Sadasivam, Balakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052757/ https://www.ncbi.nlm.nih.gov/pubmed/30078879 http://dx.doi.org/10.4103/ijd.IJD_481_17 |
Ejemplares similares
-
Fixed drug eruption due to levocetirizine
por: Jhaj, Ratinder, et al.
Publicado: (2016) -
Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough
por: Jhaj, Ratinder, et al.
Publicado: (2021) -
Black hairy tongue with a fixed dose combination of olanzapine and fluoxetine
por: Jhaj, Ratinder, et al.
Publicado: (2016) -
Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021) -
Inadequate pain relief for patients with trauma: A cause for concern?
por: Balakrishnan, Sadasivam, et al.
Publicado: (2013)